Peripartum kardiomyopati

Ditte-Marie Bretler; Casper Haslund Jørgensen; Jonas Bjerring Olesen; Gunnar Hilmar Gislason; Peter Riis Hansen; Ditte-Marie Bretler; Casper Haslund Jørgensen; Jonas Bjerring Olesen; Gunnar Hilmar Gislason; Peter Riis Hansen

Peripartum kardiomyopati

Ditte-Marie Bretler, Casper Haslund Jørgensen, Jonas Bjerring Olesen, Gunnar Hilmar Gislason, Peter Riis Hansen, Ditte-Marie Bretler, Casper Haslund Jørgensen, Jonas Bjerring Olesen, Gunnar Hilmar Gislason, Peter Riis Hansen

IKM

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition.
Udgivelsesdato: 2009-Jan-5

Bidragets oversatte titel	Peripartum cardiomyopathy
Originalsprog	Dansk
Tidsskrift	Ugeskrift for læger
Vol/bind	171
Udgave nummer	1-2
Sider (fra-til)	53-5
Antal sider	3
ISSN	0041-5782
Status	Udgivet - 5 jan. 2009

Bibliografisk note

Keywords: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors

Citationsformater

Peripartum kardiomyopati. / Bretler, Ditte-Marie; Jørgensen, Casper Haslund; Olesen, Jonas Bjerring; Gislason, Gunnar Hilmar ; Hansen, Peter Riis; Bretler, Ditte-Marie; Jørgensen, Casper Haslund; Olesen, Jonas Bjerring; Gislason, Gunnar Hilmar ; Hansen, Peter Riis.

I: Ugeskrift for læger, Bind 171, Nr. 1-2, 05.01.2009, s. 53-5.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{cbdceb5064b711df928f000ea68e967b,

title = "Peripartum kardiomyopati",

abstract = "Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition. Udgivelsesdato: 2009-Jan-5",

author = "Ditte-Marie Bretler and J{\o}rgensen, {Casper Haslund} and Olesen, {Jonas Bjerring} and Gislason, {Gunnar Hilmar} and Hansen, {Peter Riis} and Ditte-Marie Bretler and J{\o}rgensen, {Casper Haslund} and Olesen, {Jonas Bjerring} and Gislason, {Gunnar Hilmar} and Hansen, {Peter Riis}",

note = "Keywords: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors",

year = "2009",

month = jan,

day = "5",

language = "Dansk",

volume = "171",

pages = "53--5",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "1-2",

}

TY - JOUR

T1 - Peripartum kardiomyopati

AU - Bretler, Ditte-Marie

AU - Jørgensen, Casper Haslund

AU - Olesen, Jonas Bjerring

AU - Gislason, Gunnar Hilmar

AU - Hansen, Peter Riis

AU - Bretler, Ditte-Marie

AU - Jørgensen, Casper Haslund

AU - Olesen, Jonas Bjerring

AU - Gislason, Gunnar Hilmar

AU - Hansen, Peter Riis

N1 - Keywords: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors

PY - 2009/1/5

Y1 - 2009/1/5

N2 - Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition. Udgivelsesdato: 2009-Jan-5

AB - Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition. Udgivelsesdato: 2009-Jan-5

M3 - Tidsskriftartikel

VL - 171

SP - 53

EP - 55

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 1-2

ER -